Torno Capital »

BioMarin Pharmaceutical shares owned by Torno Capital

Quarter-by-quarter ownership of BioMarin Pharmaceutical (BMRN) shares owned by Torno Capital from 13F filings

Historical chart of Torno Capital investment in BioMarin Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including BioMarin Pharmaceutical held by Torno Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioMarin Pharmaceutical by Torno Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $386k 4.0k 96.42

More positions owned by Torno Capital

Sprott Fds Tr Uranium Miners E Put Option (URNM)
Spotify Technology S A SHS Put Option (SPOT)
Alphabet Cap Stk Cl A (GOOGL)
Global X Fds Global X Uranium Put Option (URA)
Ishares Msci Sth Kor Etf Put Option (EWY)
Colgate-Palmolive Company Put Option (CL)
Caterpillar Call Option (CAT)
BlackRock Call Option (BLK)
Booz Allen Hamilton Hldg Cor Cl A Call Option (BAH)
United States Stl Corp New Com Put Option (X)
Vertex Pharmaceuticals Incorporated Put Option (VRTX)
Incyte Corporation Call Option (INCY)
Realty Income Call Option (O)
Rio Tinto Sponsored Adr Call Option (RIO)
Regeneron Pharmaceuticals Put Option (REGN)

View all positions for Torno Capital

Top funds holding BioMarin Pharmaceutical

PRIMECAP Management Company
Vanguard Group
BlackRock
Dodge & Cox
Barclays
Viking Global Investors
venBio Select Advisor
Deutsche Bank Aktiengesellschaft
Norges Bank Investment Management
Elliott Investment Management
Henderson Group
Bank of New York Mellon
Jpmorgan Chase & Co
Bank of America Corporation
Nomura Holdings

View all funds holding BioMarin Pharmaceutical